MSF's publications are an expression of our belief in the principle of témoignage, or bearing witness, and the belief that we are accountable to those we work for and with. Sharing news about our activities and reflecting on them, offering critiques when necessary, are therefore crucial aspects of our work.

View and download these publications below.

To view the U.S. Annual Reports or International Activity Reports, please visit the Annual Reports page.

Country/Region

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

April 21, 2016

Concha Fernández is the project coordinator for two of the Doctors Without Borders/Médecins Sans Frontières (MSF) teams currently responding to medical needs in Ecuador following the 7.8 magnitude earthquake that struck the northeast of the country on April 16. According to official figures, 570 people are confirmed dead, more than 7,000 are injured, and 155 people remain missing. More than 24,400 people are now living in shelters. Early Wednesday morning, a powerful aftershock measuring 6.1 on the Richter scale struck about 25 kilometers west of Muisne, one of the hardest-hit areas.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

July 31, 2012

MSF is working with Sierra Leone's Ministry of Health to counter a deadly cholera outbreak in the capital, Freetown.

July 05, 2017

Two days ahead of the G20 summit in Germany, the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) and the Stop TB Partnership released a report that shows countries are lagging behind in tackling tuberculosis (TB), introducing the best diagnostic devices, and implementing globally-recommended policies. The third edition of the “Out of Step” report reviews TB policies and practices in 29[1] countries–which account for 82 percent of the global TB burden–and shows that countries can do much more to prevent, diagnose, and treat people affected by TB.

April 21, 2016

Concha Fernández is the project coordinator for two of the Doctors Without Borders/Médecins Sans Frontières (MSF) teams currently responding to medical needs in Ecuador following the 7.8 magnitude earthquake that struck the northeast of the country on April 16. According to official figures, 570 people are confirmed dead, more than 7,000 are injured, and 155 people remain missing. More than 24,400 people are now living in shelters. Early Wednesday morning, a powerful aftershock measuring 6.1 on the Richter scale struck about 25 kilometers west of Muisne, one of the hardest-hit areas.

February 24, 2016

International medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today expressed great concern at the high price announced for the new tuberculosis (TB) drug delamanid. Japanese pharmaceutical company Otsuka said that it would make delamanid available to some developing countries at a price of $1,700 per treatment course.

July 31, 2012

MSF is working with Sierra Leone's Ministry of Health to counter a deadly cholera outbreak in the capital, Freetown.